TD Cowen Initiates Coverage on Certara (NASDAQ:CERT)

TD Cowen started coverage on shares of Certara (NASDAQ:CERT - Free Report) in a research report sent to investors on Thursday morning, MarketBeat reports. The brokerage issued a buy rating and a $16.00 target price on the stock.

A number of other equities research analysts have also recently issued reports on the company. Barclays decreased their target price on Certara from $14.00 to $12.00 and set an "equal weight" rating for the company in a research report on Thursday, November 7th. Robert W. Baird reduced their price objective on shares of Certara from $18.00 to $13.00 and set a "neutral" rating for the company in a research note on Tuesday, November 5th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $15.83.

Certara Stock Down 0.3 %

Shares of NASDAQ:CERT traded down $0.04 on Thursday, reaching $11.94. The company had a trading volume of 1,897,806 shares, compared to its average volume of 965,492. The stock has a market capitalization of $1.92 billion, a P/E ratio of -59.70, a P/E/G ratio of 9.29 and a beta of 1.57. The stock has a 50-day moving average price of $12.45 and a 200 day moving average price of $11.63. Certara has a twelve month low of $9.41 and a twelve month high of $19.87. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.28.

Remove Ads

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Vanguard Group Inc. increased its position in Certara by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 12,437,089 shares of the company's stock worth $132,455,000 after acquiring an additional 38,068 shares during the period. Wasatch Advisors LP grew its position in Certara by 22.4% in the 3rd quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company's stock worth $105,577,000 after purchasing an additional 1,651,076 shares during the last quarter. ArrowMark Colorado Holdings LLC increased its holdings in shares of Certara by 164.2% during the 4th quarter. ArrowMark Colorado Holdings LLC now owns 6,213,278 shares of the company's stock worth $66,171,000 after purchasing an additional 3,861,674 shares during the period. Geneva Capital Management LLC raised its position in shares of Certara by 0.7% during the third quarter. Geneva Capital Management LLC now owns 5,510,209 shares of the company's stock valued at $64,525,000 after buying an additional 37,392 shares during the last quarter. Finally, Teacher Retirement System of Texas raised its position in shares of Certara by 13.9% during the fourth quarter. Teacher Retirement System of Texas now owns 4,557,951 shares of the company's stock valued at $48,542,000 after buying an additional 557,348 shares during the last quarter. 73.96% of the stock is currently owned by institutional investors and hedge funds.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.